New Leaf Venture Partners, L.L.C. Passage Bio, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $43.2 Million
- Q3 2025
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Passage Bio, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 87,426 shares of PASG stock, worth $724,761. This represents 1.66% of its overall portfolio holdings.
Number of Shares
87,426
Previous 2,497,922
96.5%
Holding current value
$724,761
Previous $999,000
28.33%
% of portfolio
1.66%
Previous 2.97%
Shares
2 transactions
Others Institutions Holding PASG
# of Institutions
5Shares Held
905KCall Options Held
0Put Options Held
0About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $451M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...